| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/11/2007 | US20070009590 Physiologically active composition based on phosphatidylserine |
| 01/11/2007 | US20070009588 comprises fentanyl as active ingredient, pressure-sensitive adhesive base, and tackifier resin; pressure-sensitive adhesive base comprising polyisobutylene and styrene/isoprene/styrene block copolymer; easily produced, has long-term continuity, and is excellent in adhesion and conformability to skin |
| 01/11/2007 | US20070009586 Wound dressings containing complexes of transition metals and alginate for elastase sequestering |
| 01/11/2007 | US20070009578 Haemostatic composition comprising hyaluronic acid |
| 01/11/2007 | US20070009576 Nutritionally fortified liquid composition with added value delivery systems/elements/additives |
| 01/11/2007 | US20070009574 Food product providing sustained blood levels of exogenous substances |
| 01/11/2007 | US20070009558 Sugar-free storage-stable antihistaminic syrups |
| 01/11/2007 | US20070009552 Simultaneous protection against each of the four dengue viruses, thereby precluding the possibility of developing the more serious illnesses dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), which occur in humans during secondary infection with a heterotypic wild-type dengue virus |
| 01/11/2007 | US20070009538 Expression and export of angiogenesis inhibitors as immunofusins |
| 01/11/2007 | US20070009535 Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism |
| 01/11/2007 | US20070009534 Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism |
| 01/11/2007 | US20070009533 Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism |
| 01/11/2007 | US20070009532 Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar |
| 01/11/2007 | US20070009531 Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar |
| 01/11/2007 | US20070009530 Antitumor agents; antiproliferative agents; neurodegenerative diseases; using interfering rna; antagonist hedgehog gene; blocking antibodies |
| 01/11/2007 | US20070009529 Agents that dissolve arterial thrombi |
| 01/11/2007 | US20070009517 Method of inducing immune tolerance |
| 01/11/2007 | US20070009509 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor |
| 01/11/2007 | US20070009496 Method of growing myocardial cells |
| 01/11/2007 | US20070009495 Method for treating or preventing systemic inflammation in formula-fed infants |
| 01/11/2007 | US20070009488 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules |
| 01/11/2007 | US20070009485 dextrin polymers in combination with sugars provide enhanced delivery of nucleic acids, particularly eucaryotic expression vectors, demonstrate enhanced delivery of nucleic acids to cells in vivo |
| 01/11/2007 | US20070009484 Compositions and methods involving MDA-7 for the treatment of cancer |
| 01/11/2007 | US20070009482 Stimulant of immunology response; viricides |
| 01/11/2007 | US20070009476 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| 01/11/2007 | US20070009474 Personal care compositions and methods for the beautification of mammalian skin and hair |
| 01/11/2007 | US20070009451 Cosmetic and/or pharmaceutical compositions for the cure and prevention of irritation, inflammation and cutaneous erythema |
| 01/11/2007 | US20070009445 Aerosol compositions and methods |
| 01/11/2007 | US20070009444 Method for preparing powder exhibiting low susceptibility to electrification |
| 01/11/2007 | US20070009432 Boat tropanes |
| 01/11/2007 | DE19713543B4 Bakterielle Plasmide Bacterial plasmids |
| 01/11/2007 | DE10246377B4 Verfahren zur Herstellung von Pflastersystemen mit dotierten Trägermaterialien als Reservoir A process for the production of paving systems with doped support materials as a reservoir |
| 01/11/2007 | DE102005031580A1 Substituierte Sulfolanylpyrazole und ihre Verwendung Substituted Sulfolanylpyrazole and their use |
| 01/11/2007 | DE102005031577A1 Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and / or nisoldipine and an angiotensin II antagonist |
| 01/11/2007 | DE102005031575A1 Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Förderung der Wundheilung Use of activators of soluble guanylate cyclase to promote wound healing |
| 01/11/2007 | DE102005030292A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
| 01/11/2007 | DE102005028862A1 Substituierte Heterocyclen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Substituted heterocycles, their use as a medicament as well as pharmaceutical compositions containing them |
| 01/11/2007 | DE102004040736B4 Verfahren zur Herstellung von Diarylcycloalkylderivaten A process for preparing Diarylcycloalkylderivaten |
| 01/11/2007 | CA2642008A1 Methods and compositions for improving pregnancy outcome |
| 01/11/2007 | CA2616918A1 Mao-b inhibitors useful for treating obesity |
| 01/11/2007 | CA2614347A1 Pharmaceutical composition comprising simvastatin and ezetimibe |
| 01/11/2007 | CA2614315A1 Activator of peroxisome proliferator activated receptor d |
| 01/11/2007 | CA2614312A1 Drug-introduced photo-crosslinked hyaluronic acid derived gel |
| 01/11/2007 | CA2614282A1 Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
| 01/11/2007 | CA2614244A1 Combinations of eszopiclone and an antidepressant |
| 01/11/2007 | CA2614226A1 High yield synthesis methods for producing organic salts of strontium |
| 01/11/2007 | CA2614210A1 Methods and compositions for improving pregnancy outcome |
| 01/11/2007 | CA2614209A1 Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
| 01/11/2007 | CA2614193A1 Zofenopril calcium in polymorph form c |
| 01/11/2007 | CA2614148A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 01/11/2007 | CA2614116A1 Histamine h3 receptor antagonists |
| 01/11/2007 | CA2614110A1 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 01/11/2007 | CA2614105A1 Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents |
| 01/11/2007 | CA2614102A1 Core 2 glcnac-t inhibitors |
| 01/11/2007 | CA2614098A1 Thiazoles derivatives as ampk activator |
| 01/11/2007 | CA2614089A1 Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| 01/11/2007 | CA2614083A1 Use of activators of the soluble guanylate cyclase for promoting the healing of wounds |
| 01/11/2007 | CA2614070A1 Cathepsin cysteine protease inhibitors |
| 01/11/2007 | CA2614049A1 Method of biomolecule immobilization on polymers using click-type chemistry |
| 01/11/2007 | CA2614017A1 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 01/11/2007 | CA2614002A1 Combination therapy of cancer with azd2171 and gemcitabine |
| 01/11/2007 | CA2613962A1 Alkenyldiarylmethanes, fused analogs and syntheses thereof |
| 01/11/2007 | CA2613911A1 Crystalline forms of macrolide compounds endowed with antiinflammatory activity |
| 01/11/2007 | CA2613905A1 The treatment of inflammatory disorders and pain |
| 01/11/2007 | CA2613895A1 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
| 01/11/2007 | CA2613875A1 Improved drug or pharmaceutical compounds and a preparation thereof |
| 01/11/2007 | CA2613860A1 Novel hydroxamic acid-containing amino acid derivatives |
| 01/11/2007 | CA2613828A1 Novel medicinal combinations which are used for treating respiratory tract diseases and contain beta-2 long-acting agonists and at least one other type of active substance. |
| 01/11/2007 | CA2613795A1 Inhibitors of fibroblast activation protein alpha |
| 01/11/2007 | CA2613664A1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 01/11/2007 | CA2613636A1 Compositions for treating or preventing obesity and insulin resistance disorders |
| 01/11/2007 | CA2613585A1 Combination of a renin inhibitor and an insulin secretion enhancer or an insulin sensitizer |
| 01/11/2007 | CA2613435A1 Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation |
| 01/11/2007 | CA2613428A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands |
| 01/11/2007 | CA2613365A1 Phenoxy acetic acids as ppar delta activators |
| 01/11/2007 | CA2613350A1 Glycolipid derivative and drug containing the same as active component |
| 01/11/2007 | CA2613345A1 Compositions ameliorating a reduced diurnal activity and/or depressive symptoms |
| 01/11/2007 | CA2613343A1 Compositions comprising arachidonic acid and docosapentaenoic acid for ameliorating reduced higher brain functions resyktubg from organic brain lesions |
| 01/11/2007 | CA2613236A1 G-protein coupled receptor agonists |
| 01/11/2007 | CA2613235A1 Gpcr agonists |
| 01/11/2007 | CA2613211A1 Pyrroloquinoline derivatives and their use as protein kinase inhibitors |
| 01/11/2007 | CA2613192A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/11/2007 | CA2613112A1 Hcv inhibitors |
| 01/11/2007 | CA2613068A1 Indole carboxamides as ikk2 inhibitors |
| 01/11/2007 | CA2613059A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments |
| 01/11/2007 | CA2613053A1 Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile and methods of preparing the same |
| 01/11/2007 | CA2613045A1 Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation |
| 01/11/2007 | CA2612893A1 Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 01/11/2007 | CA2612721A1 Platinum complexes with mononitrile-containing ligands |
| 01/11/2007 | CA2612710A1 Diazo ligand platinum analogs |
| 01/11/2007 | CA2612621A1 Heparin coating of biological tissue |
| 01/11/2007 | CA2612591A1 Heterocyclic compounds as agonists for the thyroid receptor |
| 01/11/2007 | CA2612441A1 Oral composition comprising dimethicone copolyol |
| 01/11/2007 | CA2612142A1 Process for synthesizing a cetp inhibitor |
| 01/11/2007 | CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/11/2007 | CA2611688A1 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 01/11/2007 | CA2611684A1 A-[(e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid analogs and method of manufacture and use thereof |
| 01/11/2007 | CA2611438A1 Cyclic anilino-pyridinotriazines |
| 01/11/2007 | CA2611125A1 Prolonged release formulation of active principles having a ph-dependent solubility |
| 01/11/2007 | CA2605128A1 Syntheses and preparations of polymorphs of crystalline aripiprazole |